The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Aspire Products sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Aspire Products is a medical device company that manufactures and distributes respiratory products. It’s expiratory muscle strength training (EMST) 150, is a scientifically tested handheld device that improves muscle strength and will improve basic breathing-related functions such as cough, swallowing and speech. The EMST 150 produced significant improvements in both healthy individuals and persons with Parkinson’s, multiple sclerosis, spinal cord injury, and other types of neuromuscular disease. Other key products include EMST75 Lite and IA150 Inspiratory Adapter, used to strengthen the inspiratory muscles strength. Aspire Products is headquartered in Cedar Point, North Carolina, the US.
The key metrics of Aspire Products related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Aspire Products is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Aspire Products.
For a detailed understanding of the performance of Aspire Products, buy the report here.